Local Institution - 0121

Porto Alegre, Rio Grande do Sul 90610-000

1 studies enrolling now · 1 studies all time

What they study most

Urothelial Cancer

Studies at this site

• Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy — Recruiting now